Cargando…

Synthesis, Biological Evaluation, and SAR Studies of 14β-phenylacetyl Substituted 17-cyclopropylmethyl-7, 8-dihydronoroxymorphinones Derivatives: Ligands With Mixed NOP and Opioid Receptor Profile

A series of 14β-acyl substituted 17-cyclopropylmethyl-7,8-dihydronoroxymorphinone compounds has been synthesized and evaluated for affinity and efficacy for mu (MOP), kappa (KOP), and delta (DOP) opioid receptors and nociceptin/orphanin FQ peptide (NOP) receptors. The majority of the new ligands dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Vinod, Polgar, Willma E., Cami-Kobeci, Gerta, Thomas, Mark P., Khroyan, Taline V., Toll, Lawrence, Husbands, Stephen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156383/ https://www.ncbi.nlm.nih.gov/pubmed/30283364 http://dx.doi.org/10.3389/fpsyt.2018.00430

Ejemplares similares

In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential
por: Khroyan, Taline V., et al.
Publicado: (2017)

Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity
por: Greedy, Benjamin M., et al.
Publicado: (2013)

COVID-19 and Parkinson’s Disease: Shared Inflammatory Pathways Under Oxidative Stress †
por: Chaudhry, Zahara L., et al.
Publicado: (2020)

Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships
por: Journigan, V. Blair, et al.
Publicado: (2017)

Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors
por: Zaveri, Nurulain T., et al.
Publicado: (2015)

2-Phenyl-N′-(2-phenylacetyl)acetohydrazide
por: Abdel-Aziz, Hatem A., et al.
Publicado: (2012)

N-(2-Oxo-2-phenylacetyl)benzamide
por: Fun, Hoong-Kun, et al.
Publicado: (2010)

Phenylacetyl glutamine: a novel biomarker for stroke recurrence warning
por: Ma, Li, et al.
Publicado: (2023)

C7β-Methyl Analogues of the Orvinols: The Discovery of Kappa Opioid Antagonists with Nociceptin/Orphanin FQ Peptide (NOP) Receptor Partial Agonism and Low, or Zero, Efficacy at Mu Opioid Receptors
por: Cueva, Juan Pablo, et al.
Publicado: (2015)

Novel Mixed NOP/Opioid Receptor Peptide Agonists
por: Pacifico, Salvatore, et al.
Publicado: (2021)

Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects
por: Raffaele, Marco, et al.
Publicado: (2021)

Substitutional disorder in the substituted nixantphos ligand C(39)H(32)Br(0.27)Cl(0.73)NOP(2)
por: Marimuthu, Thashree, et al.
Publicado: (2008)

Cyclopropylmethyl Protection of Phenols: Total Synthesis of the Resveratrol Dimers Anigopreissin A and Resveratrol–Piceatannol Hybrid
por: Kumar, Arvind, et al.
Publicado: (2018)

Production of phenylacetyl-homoserine lactone analogs by artificial biosynthetic pathway in Escherichia coli
por: Kang, Sun-Young, et al.
Publicado: (2015)

Phenylacetyl-/Trolox- Amides: Synthesis, Sigma-1, HDAC-6, and Antioxidant Activities
por: Flores, Rafael, et al.
Publicado: (2023)

NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases
por: Gavioli, Elaine C., et al.
Publicado: (2011)

Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity
por: Kumar, Vinod, et al.
Publicado: (2014)

Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics
por: Dasgupta, Pooja, et al.
Publicado: (2022)

Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors
por: Wtorek, Karol, et al.
Publicado: (2022)

Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal
por: Perez, Xiomara A, et al.
Publicado: (2015)

Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)
por: Bird, Mark F., et al.
Publicado: (2016)

N,N′-Dibenzyl-N,N′-dimethyl-N′′-(2-phenylacetyl)phosphoric triamide
por: Pourayoubi, Mehrdad, et al.
Publicado: (2011)

Enrichment of Bacteria From Eastern Mediterranean Sea Involved in Lignin Degradation via the Phenylacetyl-CoA Pathway
por: Woo, Hannah L., et al.
Publicado: (2018)

MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands
por: Bird, M. F., et al.
Publicado: (2022)

A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration
por: Cippitelli, Andrea, et al.
Publicado: (2016)

Structure-Based Virtual Screening of the Nociceptin Receptor: Hybrid Docking and Shape-Based Approaches for Improved Hit Identification
por: Daga, Pankaj R., et al.
Publicado: (2014)

Parkinson’s disease: no NOP, new hope
por: Arcuri, Ludovico, et al.
Publicado: (2016)

A Proteomic Screen for Nucleolar SUMO Targets Shows SUMOylation Modulates the Function of Nop5/Nop58
por: Westman, Belinda J., et al.
Publicado: (2010)

The roles of NOP56 in cancer and SCA36
por: Zhao, Shimin, et al.
Publicado: (2023)

Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation
por: Coluzzi, Flaminia, et al.
Publicado: (2022)

2,3;5,6-Di-O-isopropylidene-1-O-(2-phenylacetyl)-α-d-mannofuranose
por: Sacui, Iulia A., et al.
Publicado: (2010)

NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/β-catenin signaling pathway
por: Li, Jingrong, et al.
Publicado: (2018)

Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer
por: Lu, Caijie, et al.
Publicado: (2022)

Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?
por: Bailey, Sarah J., et al.
Publicado: (2018)

In Vivo Delivery of RNAi by Reducible Interfering Nanoparticles (iNOPs)
por: Baigude, Huricha, et al.
Publicado: (2013)

N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2020)

Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
por: Zamora, Joshua C., et al.
Publicado: (2021)

NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway
por: Lei, Jin-Ju, et al.
Publicado: (2015)

Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Ligands
por: Harland, Aubrie A., et al.
Publicado: (2016)

NOP receptor pharmacological profile – A dynamic mass redistribution study
por: Malfacini, Davide, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l186m0vtiuj4816lqeh3l9ua5l